• A Phase 2a Study of ly4005130 in Adults with Severe Alopecia Areata

    Not yet recruiting

    2 1
    The Netherlands Poland

  • Phase Ib/II Study of Bexmarilimab Plus Doxorubicin in Adults with Metastatic Soft Tissue Sarcoma

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Short Course Amoxicillin for Children with Acute Streptococcal Pharyngotonsillitis: A Phase III Randomized Trial

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Safety and pharmacodynamics of cangrelor tetrasodium in paediatric patients with congenital heart disease undergoing percutaneous vascular procedures

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Germany The Netherlands Portugal

  • Safety and Efficacy of TSRA-196 (rnaivt9315 and rnacs24757) in Adults with Lung or Liver Disease due to Alpha‑1 Antitrypsin Deficiency

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Ireland The Netherlands Sweden

  • Safety and Efficacy of Efimosfermin Alfa in Participants with Biopsy‑Confirmed F2‑ or F3‑Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

    Not yet recruiting

    3 1
    Austria Belgium Bulgaria France Germany Greece +4

  • Efficacy of efanesoctocog alfa in reducing synovitis in patients with congenital hemophilia A – a multicenter, randomized, open‑label phase 3 trial

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Germany

  • Evaluation of FG001 imaging agent in patients with oropharyngeal and oral squamous cell carcinoma undergoing transoral robotic surgery or neck dissection

    Not yet recruiting

    2 1 1
    Investigated drugs:
    Denmark

  • Oral corticosteroid tapering with ravulizumab, prednisone and prednisolone in adult patients with generalized myasthenia gravis

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Italy

  • Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    Austria Belgium Czechia Denmark France Germany +5

powered by